Posted by Michael Wonder on 15 Jul 2025
Sun Pharma announces launch of Leqselvi (deuruxolitinib) in the US for the treatment of severe alopecia areata
14 July 2025 - Leqselvi now available for prescription in US nationwide, offering a new option for eligible patients
Sun Pharmaceutical Industries today announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US.
